SMER3

製品コードS4925 バッチS492502

印刷

化学情報

 Chemical Structure Synonyms Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C11H4N4O2

分子量 224.18 CAS No. 67200-34-4
Solubility (25°C)* 体外 DMSO (warmed with 50ºC water bath) 15 mg/mL (66.91 mM)
Water Insoluble
Ethanol Insoluble
体内 (毎回新しく調製した物を用意してください)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

0.150mg/ml (0.67mM) Taking the 1 mL working solution as an example, add 50 μL of 3 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

0.550mg/ml (2.45mM) Taking the 1 mL working solution as an example, add 50 μL of 11 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 SMER3, the small-molecule enhancer of rapamycin (SMER), is an inhibitor of the Skp1-Cullin-F-box (SCF)Met30 ubiquitin ligase with IC50 of 51 nM.
in vitro SMER3 specifically inhibits ubiquitination by recombinant reconstituted SCFMet30, selectively disassembles or prevents assembly of SCFMet30 but not other SCF complexes, and directly binds to Met30 (or Met30-Skp1 complex), but not Skp1 alone, which inhibits Met30 bounding to Skp1. This compound treatment is able to upregulate a set of methionine biosynthesis genes. It enhances rapamycin’s growth inhibitory effect by inhibition of SCFMet30 and blocking Met4 ubiquitination. [1]

プロトコル(参考用のみ)

キナーゼアッセイ SCF E3 ligase assay
GstSkp1, Cdc53, 6xHisMet30 and Rbx1 are co-expressed in Hi5 cells and SCFMet30 is purified on glutathione sepharose. Recombinant FLAG-6xHisMet4 is bound to SCFMet30 and the ligase/substrate complex is eluted with glutathione. Sic1 in vitro ubiquitination by recombinant SCFCdc4 is performed. To directly compare the effect of SMER3 on SCFMet30 and SCFCdc4, Met4 and Sic1 ubiquitination are assayed in a single reaction. Approximately 150 nM SCFMet30 and SCFCdc4 are incubated with DMSO (solvent control) or this compound for 20 min at 25 ℃. The reaction is started by addition of a final concentration of 250 nM yeast E1, 0.8 μM recombinant Cdc34 purified from E. coli36, 5 mM ATP, and 80 μM ubiquitin. Reactions are incubated at 30 ℃ and samples are taken after 5 min and 25 min reaction time to accommodate different reaction kinetics by the two SCFs. Products are separated on SDS-PAGE and analyzed by immunoblotting using anti-Met4 and anti-Sic1 antibodies.

参考

  • https://pubmed.ncbi.nlm.nih.gov/20581845/

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。